Sanofi: For sure the new CETP inhibitor’s failure is good news for PCSK9s and so for Sanofi

BUY, Fair Value EUR103 (+18%)
News published on October Tuesday 13, 2015
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities